|Bid||9.29 x 1000|
|Ask||23.50 x 800|
|Day's Range||23.07 - 23.56|
|52 Week Range||22.28 - 43.00|
|Beta (5Y Monthly)||0.98|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.50|
GOLETA, Calif., October 05, 2022--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third quarter 2022 financial results before the market opens on Wednesday, November 2, 2022. On the same day, the Company will host a conference call beginning at 5:30 am PT / 8:30 am ET.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.